Results 111 to 120 of about 11,842 (181)

Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist. [PDF]

ACS Pharmacol Transl Sci
De Fenza M, Locri F, Plastino F, Chino M, Maglio O, Leone L, Gazzaroli G, Belleri M, Giacomini A, Kvanta A, André H, Pavone V, D'Alonzo D.   +12 more
europepmc   +1 more source

Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells. [PDF]

Chembiochem, 2022
Sikorski EL, Wehr J, Ferraro NJ, Rizzo SM, Pires MM, Thévenin D.   +5 more
europepmc   +1 more source

Mesenchymal Stem Cells and Formyl Peptide Receptor 2 Activity in Hyperoxia-Induced Lung Injury in Newborn Mice. [PDF]

Int J Mol Sci, 2022
Kim YE, Ahn SY, Sung DK, Chang YS, Park WS.   +4 more
europepmc   +1 more source

Intestinal epithelial formyl peptide receptor 2 contributes to intestinal epithelium homeostasis and injury repair by regulating intestinal stem cell and transit-amplifying cell proliferation and differentiation. [PDF]

Life Metab
Yu S, Song L, Wunier, Ouyang S, Ding Y, Zhan L, Zeng YA, Le Y.   +7 more
europepmc   +1 more source

Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis. [PDF]

EMBO Mol Med
Margraf A, Chen J, Christoforou M, Claria-Ribas P, Henriques Schneider A, Cecconello C, Bu W, Imbert PRC, Wright TD, Russo S, Blacksell IA, Koenis DS, Dalli J, Lupisella JA, Wurtz NR, Garcia RA, Cooper D, Norling LV, Perretti M.   +18 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluation of Novel Heteroaryl, Squaramide, and Indolcarboxamide Derivatives as Formyl Peptide Receptor 2 Agonists to Target Neuroinflammation. [PDF]

ACS Chem Neurosci
Francavilla F, Vitone D, Schepetkin IA, Kirpotina LN, Carrieri A, Brunetti L, Ghafir El Idrissi I, Perrone MG, Frydrych JK, Trojan E, Quinn MT, Basta-Kaim A, Lacivita E, Leopoldo M.   +13 more
europepmc   +1 more source

The neutrophil extracellular trap-related gene FPR1 (formyl peptide receptor 1) as a potential prognostic and therapeutic target in osteosarcoma. [PDF]

BMC Musculoskelet Disord
Li S, Yuan Q, Zhang Y, Zhang H.
europepmc   +1 more source

Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils. [PDF]

ACS Pharmacol Transl Sci
Abdel-Halim M, Wagdy RA, Salah M, Wang YH, Cheng TP, Lee YR, Chen YC, Mandour YM, Abadi AH, Engel M, Hwang TL.   +10 more
europepmc   +1 more source

Increased expression of formyl peptide receptor-1 by basophils from patients with mastocytosis. [PDF]

J Allergy Clin Immunol Glob
Yin Y, Li JM, Metcalfe DD, Olivera A, Frischmeyer-Guerrerio PA, Carter MC, Komarow H.   +6 more
europepmc   +1 more source

Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists. [PDF]

ACS Med Chem Lett
Wurtz NR, Shirude PS, Cheney DL, Lupisella JA, Chattopadhyay AK, Baligar V, Seshadri B, Anjanappa P, Viet A, Valente MN, Hsu MY, Abousleiman M, Sarodaya S, Tagore DM, Dudhgaonkar S, Putlur S, Dierks EA, Ostrowski J, Wexler RR, Garcia R, Kick EK.   +20 more
europepmc   +1 more source